Global Artificial Heart-Lung Machine Market Report, 2019-2024 Outlook - ResearchAndMarkets.com

DUBLIN--()--The "Artificial Heart-Lung Machine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global artificial heart-lung machine market was worth US$ 281.4 Million in 2018. Looking forward, the market is projected to reach a value of US$ 410.7 Million by 2024, registering a CAGR of 6.5% during 2019-2024.

In recent years, there has been a significant rise in the number of open-heart surgeries, heart transplants and lung surgeries across the globe. This can primarily be attributed to various environmental and lifestyle changes, which have led to an increase in the prevalence of cardiovascular diseases and the instances of organ failures.

Other than this, governments of several developing nations are making efforts for providing improved healthcare facilities to patients, which is driving the demand for artificial heart-lung machines.

Furthermore, the market players are investing in research and development activities to modernize the current models of oxygenator pumps. These activities have led to the development of modular heart-lung machines that are cost-effective, safe, and user-friendly in nature. Besides this, these machines also offer flexibility to doctors as they are portable and can be operated on rechargeable batteries. The manufacturers have also made several improvements in CPB pumps to prevent the over-oxygenation of blood.

Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Inc, Sorin Group, MAQUET GmbH & Co. KG, Terumo Corporation, C.R. Bard Inc, Tianjin Medical, Edwards Lifesciences, Jarvik Heart, Braile Biomdica, SynCardia, etc.

Key Questions Answered in This Report

  • How has the global artificial heart-lung machine market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global artificial heart-lung machine industry?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the global artificial heart-lung machine industry?
  • What are the key driving factors and challenges in the global artificial heart-lung machine industry?
  • What is the structure of the global artificial heart-lung machine industry and who are the key players?
  • What is the degree of competition in the global artificial heart-lung machine industry?

Key Topics Covered

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Artificial Heart-Lung Machine Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Type

5.4 Market Breakup by Application

5.5 Market Breakup by End User

5.6 Market Breakup by Region

5.7 Market Forecast

6 Market Breakup by Type

6.1 Single Roller Pump

6.2 Double Roller Pump

7 Market Breakup by Application

7.1 Cardiac Surgeries

7.2 Lung Surgeries

7.3 Acute Respiratory Failure Treatment

7.4 Others

8 Market Breakup by End User

8.1 Hospitals and Clinics

8.2 Ambulatory Surgical Centers

8.3 Others

9 Market Breakup by Region

9.1 North America

9.2 Europe

9.3 Asia Pacific

9.4 Middle East and Africa

9.5 Latin America

10 SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Value Chain Analysis

12 Porter's Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

14.3.1 Medtronic Inc

14.3.2 Sorin Group

14.3.3 MAQUET GmbH & Co. KG

14.3.4 Terumo Corporation

14.3.5 C.R. Bard Inc

14.3.6 Tianjin Medical

14.3.7 Edwards Lifesciences

14.3.8 Jarvik Heart

14.3.9 Braile Biomedica

14.3.10 SynCardia

For more information about this report visit https://www.researchandmarkets.com/r/7oj4s8

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900